Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
- 29 February 2012
- journal article
- Published by Elsevier BV in Clinical Nutrition
- Vol. 31 (1), 74-77
- https://doi.org/10.1016/j.clnu.2011.08.008
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- What's new in perioperative nutritional support?Current Opinion In Anesthesiology, 2011
- Would you buy a new tool to improve your practice?Current Opinion in Clinical Nutrition and Metabolic Care, 2011
- Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysisThe American Journal of Clinical Nutrition, 2010
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic CancerClinical Cancer Research, 2009
- Nutritional management during neoadjuvant therapy for esophageal cancerJournal of Surgical Oncology, 2009
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine TreatmentClinical Cancer Research, 2009
- Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) Preserves Lean Body Mass Following Esophageal Cancer Surgery: Results of a Double-Blinded Randomized Controlled TrialAnnals of Surgery, 2009
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyThe Lancet Oncology, 2008
- Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal CancerThe New England Journal of Medicine, 2006
- Weight Loss with Physiologic ImpairmentAnnals of Surgery, 1988